The estimated Net Worth of Jan Stern Reed is at least $224 Mille dollars as of 24 July 2017. Ms. Reed owns over 316 units of Angiodynamic Inc stock worth over $2,345 and over the last 21 years she sold ANGO stock worth over $0. In addition, she makes $222,008 as Independent Director at Angiodynamic Inc.
Jan has made over 2 trades of the Angiodynamic Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently she bought 316 units of ANGO stock worth $5,056 on 24 July 2017.
The largest trade she's ever made was buying 1,000 units of Angiodynamic Inc stock on 27 October 2015 worth over $51,210. On average, Jan trades about 47 units every 23 days since 2003. As of 24 July 2017 she still owns at least 316 units of Angiodynamic Inc stock.
You can see the complete history of Ms. Reed stock trades at the bottom of the page.
Jan Stern Reed J.D. serves as Independent Director of the Company. Ms. Reed was most recently Senior Vice President, General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc., a global pharmacy-led, health and wellbeing enterprise with annual revenues in excess of $115 billion. Prior to this role, Ms. Reed served as Executive Vice President of Human Resources, General Counsel and Corporate Secretary of Solo Cup Company, and Associate General Counsel, Corporate Secretary and Chief Governance Officer at Baxter International Inc. Ms. Reed earned a Bachelor of Arts degree, with honors, in Psychology from the University of Michigan, and a Juris Doctor from Northwestern University School of Law. Ms. Reed also currently serves as a member of the Board of Directors for Stepan Company (NYSE:SCL). Ms. Reed is a member of our Audit Committee and Nominating, Compliance and Corporate Governance Committee. During the fiscal year ended May 31, 2018, Ms. Reed was a member of our Audit Committee.
As the Independent Director of Angiodynamic Inc, the total compensation of Jan Reed at Angiodynamic Inc is $222,008. There are 15 executives at Angiodynamic Inc getting paid more, with James Clemmer having the highest compensation of $3,116,630.
Jan Reed is 60, she's been the Independent Director of Angiodynamic Inc since 2016. There are 2 older and 23 younger executives at Angiodynamic Inc. The oldest executive at Angiodynamic Inc is Dennis Meteny, 67, who is the Independent Director.
Jan's mailing address filed with the SEC is 14 PLAZA DRIVE, , LATHAM, NY, 12110.
Over the last 20 years, insiders at Angiodynamic Inc have traded over $207,843,757 worth of Angiodynamic Inc stock and bought 255,612 units worth $3,086,102 . The most active insiders traders include David F Burgstahler, Sriram Venkataraman e Capital Partners Gp, Llc Av.... On average, Angiodynamic Inc executives and independent directors trade stock every 36 days with the average trade being worth of $826,492. The most recent stock trade was executed by Laura Piccinini on 17 July 2024, trading 4,439 units of ANGO stock currently worth $32,937.
founded in 1988 in queensbury, n.y., u.s., angiodynamics is today a nasdaq-listed public company. we are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. our diverse product line includes market-leading radiofrequency ablation and nanoknife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. angiodynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. angiodynamics believes it is well poised to continue that trend. looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patie
Angiodynamic Inc executives and other stock owners filed with the SEC include: